The advantages of seniority

The senior and mezzanine segments of the leveraged loan market have remained largely immune to the pressures that have affected other areas of the market. Philip Moore looks at the factors that have contributed to this resilience

pgs13-barchart-gif

While the future may be uncertain for Pik notes and, to a lesser extent, second lien debt, bankers say that two other pivotal components of the leveraged finance market, senior debt and mezzanine, have remained resilient throughout the recent turbulence. Indeed, for the senior leveraged loan market it appears to remain a case of business as usual, with strong demand across all tranches continuing to support oversubscribed facilities.

The resilience of this market is a highly significant

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Credit risk & modelling – Special report 2021

This Risk special report provides an insight on the challenges facing banks in measuring and mitigating credit risk in the current environment, and the strategies they are deploying to adapt to a more stringent regulatory approach.

The wild world of credit models

The Covid-19 pandemic has induced a kind of schizophrenia in loan-loss models. When the pandemic hit, banks overprovisioned for credit losses on the assumption that the economy would head south. But when government stimulus packages put wads of cash in…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here